TSXV - Delayed Quote CAD

Entourage Health Corp. (ENTG.V)

0.0050

0.0000

(0.00%)

At close: January 27 at 1:29:53 PM EST

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

Key Takeaways; Cannabis Sector Vireo Growth raised $81M in oversubscribed funding round; the company aims to expand operations across seven states iAnthus acquired premium vape brand Cheetah in $1.5M all-stock deal Entourage Health to go private in union pension fund deal. Cansortium and RIV Capital finalized merger to create a multistate cannabis powerhouse Key Takeaways; […]

Market Exclusive 22 days ago

AWKNF

ITHUF

VREOF
Entourage Health Corp. Enters into Arrangement Agreement for Going-Private Transaction

TORONTO, Dec. 30, 2024 (GLOBE NEWSWIRE) -- Entourage Health Corp. (TSX-V: ENTG) (OTCQX: ETRGF) (FSE: 4WE) (the “Company” or “Entourage”) is pleased to announce that it has entered into a definitive arrangement agreement (the “Arrangement Agreement”) with 1001007762 Ontario Inc. (the “Purchaser”) and 2437653 Ontario Inc. (the “Guarantor”) pursuant to which the Purchaser will acquire all of the issued and outstanding common shares of the Company (the “Common Shares”) pursuant to a statutory plan o

GlobeNewswire 28 days ago

ETRGF
Entourage Health Reports Strong Third Quarter 2024 Financial Results

The Company achieved a total revenue of $13.6 million.Gross Profit Margins continue to demonstrate a solid performance with 30% growth year-over-year.SG&A achieves a significant reduction, reflecting the Company's notable 32% decrease year-over-year.EBITDA improves by 70% for the quarter and 65% year-over-year, reflecting progress toward profitability.Management will host a conference call on November 29, 2024, at 10 a.m. Eastern Time. TORONTO, Nov. 29, 2024 (GLOBE NEWSWIRE) -- Entourage Health

GlobeNewswire last month

ETRGF
Entourage Health to Host Third Quarter 2024 Earnings Conference Call

TORONTO, Nov. 21, 2024 (GLOBE NEWSWIRE) -- Entourage Health Corp. (TSX-V: ENTG) (OTCQX: ETRGF) (FSE:4WE) ("Entourage" or the "Company"), a Canadian producer and distributor of award-winning cannabis products, announced today that the Company's third quarter 2024 financial results will be released after market close on Thursday, November 28, 2024. The Company will host a conference call to discuss these results and provide an operational update and recap of achievements on Friday, November 29, 20

GlobeNewswire 2 months ago

ETRGF
Entourage Health Provides Company Update

TORONTO, Nov. 01, 2024 (GLOBE NEWSWIRE) -- Entourage Health Corp. (TSX-V: ENTG) (OTCQX: ETRGF) (FSE:4WE) ("Entourage" or the "Company"), a Canadian producer and distributor of award-winning cannabis products, announced earlier it was in breach of certain financial covenants and other obligations under each of its Senior Credit Agreement and Subordinated Credit agreements with an affiliate of the LiUNA Pension Fund of Central and Eastern Canada (“LPF”). The Company is working collaboratively with

GlobeNewswire 2 months ago

ETRGF
Entourage Health Increases Senior Secured Credit Facility

TORONTO, Oct. 24, 2024 (GLOBE NEWSWIRE) -- Entourage Health Corp. (TSX-V: ENTG) (OTCQX: ETRGF) (FSE: 4WE) ("Entourage" or the "Company"), a Canadian producer and distributor of award-winning cannabis products, confirmed today it has signed an amendment (the "Amendment") to its senior secured amended and restated credit facility entered into on January 31, 2023 (the "Credit Facility") with an affiliate of the LiUNA Pension Fund of Central and Eastern Canada ("LPF"). The Amendment provides an incr

GlobeNewswire 3 months ago

ETRGF
Entourage Health Second Quarter 2024 Earnings: CA$0.03 loss per share (vs CA$0.031 loss in 2Q 2023)

Entourage Health ( CVE:ENTG ) Second Quarter 2024 Results Key Financial Results Revenue: CA$9.26m (down 9.0% from 2Q...

Simply Wall St. 4 months ago

ETRGF
Entourage Health Reports Second Quarter 2024 Financial Results

Total revenue of $12.2 million demonstrates the Company's solid momentum year over year and ongoing growth in the rapidly expanding bulk sales market.Entourage made a strong impact with new product launches across Alberta, Ontario, and British Columbia, including Color Cannabis' expanded flower offerings.Dime Bag continued its strong performance in Ontario, achieving a sequential increase in sales and hitting a distribution milestone of over 90% coverage.Entourage continues to yield positive out

GlobeNewswire 4 months ago

ETRGF
Entourage Health to Host Second Quarter 2024 Financial Results Call

TORONTO, Aug. 06, 2024 (GLOBE NEWSWIRE) -- Entourage Health Corp. (TSX-V: ENTG) (OTCQX: ETRGF) (FSE:4WE) ("Entourage" or the "Company"), a Canadian producer and distributor of award-winning cannabis products, announced today that the Company's second quarter 2024 financial results will be released after market close on Monday, August 26, 2024. The Company will host a conference call to discuss the results and provide an operational update and recap of achievements on Tuesday, August 27, 2024. Co

GlobeNewswire 5 months ago

ETRGF
Entourage Announces Results of 2024 Annual General Meeting of Shareholders

TORONTO, June 12, 2024 (GLOBE NEWSWIRE) -- Entourage Health Corp. (TSX-V:ENTG) (OTCQX:ETRGF) (FSE:4WE) (“Entourage” or the “Company”), a Canadian producer and distributor of award-winning cannabis products, is pleased to announce that shareholders overwhelmingly approved all proposed resolutions at its annual general meeting of shareholders (“AGM”) held virtually on June 12, 2024. All director nominees, as listed in the Management Information Circular dated May 3, 2024, were elected as directors

GlobeNewswire 7 months ago

ETRGF
Entourage Health Reports First Quarter 2024 Financial Results: Achieves $16.4 Million in Total Revenue and Marks First EBITDA-Positive Quarter

Entourage's solid financial performance entering 2024 underscores its positive trajectory and positions the Company for continued success in upcoming quartersTotal revenue of $16.4 million represents a 9% increase year-over-year and a 23% sequential increase from Q4 2023.Gross profit before fair value changes improved by 92% year-over-year, leading to a record gross margin of 45%. This achievement reflects the successful execution of last year’s transformation plans.EBITDA improved by $4.4 milli

GlobeNewswire 7 months ago

ETRGF
Entourage Health to Hold First Quarter 2024 Financial Results Call on May 28

Financial filings are expected after the market closes on May 27, and a management conference call will follow the next dayTORONTO, May 14, 2024 (GLOBE NEWSWIRE) -- Entourage Health Corp. (TSX-V:ENTG) (OTCQX: ETRGF) (FSE:4WE) (“Entourage” or the “Company”), a Canadian producer and distributor of award-winning cannabis products announced today it will file its first quarter 2024 financial statements and management’s discussion and analysis after market close on Monday, May 27, 2024. Entourage wil

GlobeNewswire 8 months ago

ETRGF
Entourage Health Introduces New Product Launches and Expands Market Reach of Leading Brand Dime Bag®

Entourage Unveils Exciting New Product Offerings Diversifying the Company’s Signature BrandsDime Bag® Widens Reach: Popular Offerings Now Across Alberta TORONTO, May 08, 2024 (GLOBE NEWSWIRE) -- Entourage Health Corp. (TSX-V: ENTG) (OTCQX: ETRGF) (FSE:4WE) ("Entourage" or the "Company"), an established Canadian producer and distributor of award-winning cannabis products, today unveiled the expansion of its product portfolio. Entourage also announced the expansion of Dime Bag-branded pre-rolls in

GlobeNewswire 8 months ago

ETRGF
Entourage Health Full Year 2023 Earnings: CA$0.15 loss per share (vs CA$0.40 loss in FY 2022)

Entourage Health ( CVE:ENTG ) Full Year 2023 Results Key Financial Results Revenue: CA$40.7m (flat on FY 2022). Net...

Simply Wall St. 8 months ago

ETRGF
Entourage Health Reports Fiscal Year 2023 Financial Results and Posts $54 Million in Total Revenues

Strategic Cost Management Signals Stronger Financial Health and Future StabilityGross profit before fair value changes reached $2.4 million, reflecting a 126% year-over-year increase.Company demonstrates financial gains with a 23% reduction in the cost of goods sold.SG&A declined 14% compared to the previous year.Color Cannabis secures a #6 spot in the national pre-roll market. TORONTO, April 30, 2024 (GLOBE NEWSWIRE) -- Entourage Health Corp. (TSX-V: ENTG) (OTCQX: ETRGF) (FSE: 4WE) ("Entourage"

GlobeNewswire 8 months ago

ETRGF
Entourage Health to Report Fiscal Year 2023 Financial Results

Company Financials for Full-Year 2023 will be filed after market close on April 29, 2024TORONTO, April 24, 2024 (GLOBE NEWSWIRE) -- Entourage Health Corp. (TSX-V: ENTG) (OTCQX: ETRGF) (FSE:4WE) ("Entourage" or the "Company"), a Canadian producer and distributor of award-winning cannabis products, announced today that it will file its financial statements and management's discussion and analysis for the fourth quarter and fiscal year ended December 31, 2023, after market close on April 29, 2024.

GlobeNewswire 8 months ago

ETRGF

Performance Overview

Return	ENTG.V	S&P/TSX Composite index
YTD	0.00%	+2.72%
1-Year	-50.00%	+19.71%
3-Year	-94.44%	+22.79%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Entourage Health Corp. (ENTG.V)

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

Entourage Health Corp. Enters into Arrangement Agreement for Going-Private Transaction

Entourage Health Reports Strong Third Quarter 2024 Financial Results

Entourage Health to Host Third Quarter 2024 Earnings Conference Call

Entourage Health Provides Company Update

Entourage Health Increases Senior Secured Credit Facility

Entourage Health Second Quarter 2024 Earnings: CA$0.03 loss per share (vs CA$0.031 loss in 2Q 2023)

Entourage Health Reports Second Quarter 2024 Financial Results

Entourage Health to Host Second Quarter 2024 Financial Results Call

Entourage Announces Results of 2024 Annual General Meeting of Shareholders

Entourage Health Reports First Quarter 2024 Financial Results: Achieves $16.4 Million in Total Revenue and Marks First EBITDA-Positive Quarter

Entourage Health to Hold First Quarter 2024 Financial Results Call on May 28

Entourage Health Introduces New Product Launches and Expands Market Reach of Leading Brand Dime Bag®

Entourage Health Full Year 2023 Earnings: CA$0.15 loss per share (vs CA$0.40 loss in FY 2022)

Entourage Health Reports Fiscal Year 2023 Financial Results and Posts $54 Million in Total Revenues

Entourage Health to Report Fiscal Year 2023 Financial Results

Performance Overview